Robert C. Goeltz II insider trades: Arcus Biosciences (RCUS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Robert reports to the SEC
Open-market buys and sales
12 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 11, 2026 | RCUS | ↓ Sell10b5-1 | 7,763 | $25.63 | $199K | Direct | May 12, 2026 (1d) |
| Dec 31, 2025 | RCUS | ↓ Sell | 6,552 | $23.38 | $153K | Direct | Jan 2, 2026 (2d) |
| Dec 17, 2025 | RCUS | ↓ Sell | 12,662 | $22.01 | $279K | Direct | Dec 18, 2025 (1d) |
| Nov 26, 2025 | RCUS | ↓ Sell10b5-1 | 5,000 | $25.00 | $125K | Direct | Nov 26, 2025 (0d) |
| Oct 28, 2025 | RCUS | ↓ Sell10b5-1 | 5,000 | $20.00 | $100K | Direct | Oct 29, 2025 (1d) |
| Dec 31, 2024 | RCUS | ↓ Sell10b5-1 | 3,594 | $15.00 | $54K | Direct | Jan 3, 2025 (3d) |
| Jan 2, 2024 | RCUS | ↓ Sell10b5-1 | 2,004 | $20.00 | $40K | Direct | Jan 4, 2024 (2d) |
| Jun 7, 2023 | RCUS | ↓ Sell10b5-1 | 4,049 | $20.04 | $81K | Direct | Jun 9, 2023 (2d) |
| Dec 16, 2022 | RCUS | ↓ Sell | 2,453 | $30.75 | $75K | Direct | Dec 16, 2022 (0d) |
| Dec 17, 2021 | RCUS | ↓ Sell | 1,106 | $40.12 | $44K | Direct | Dec 20, 2021 (3d) |
| Sep 9, 2020 | RCUS | ↑ Buy | 5,000 | $21.57 | $108K | Direct | Sep 9, 2020 (0d) |
| Mar 20, 2017 | CTMX | ↓ Sell | 21,517 | $19.81 | $426K | Direct | Mar 21, 2017 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other RCUS insiders
Open-market trades in the last 12 months
About Robert C. Goeltz II's insider trades
Robert C. Goeltz II is Chief Financial Officer at Arcus Biosciences (RCUS). Since Mar 20, 2017, Robert has reported 1 open-market purchase worth $108K and 11 sales worth $1.6M on SEC Form 4. In the last 12 months: 4 sales ($756K).
6 sales (38% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (14 filings), option exercises (8 filings), shares withheld for taxes (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RCUS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.